PenderFund Capital Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

PenderFund Capital Management’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,600	Closed	-$247K	–	189
2022 Q1	$247K	Buy	+10,600	New	+$191K	0.06%	78

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PenderFund Capital Management's OCDX Position: Q2 2022 in Review

PenderFund Capital Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 10,600 shares — an estimated $247K sold.

PenderFund Capital Management first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $247K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

PenderFund Capital Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
PenderFund Capital Management sold 10,600 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $247K.
PenderFund Capital Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
PenderFund Capital Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $247K in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on PenderFund Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.